UPDATE : Monday, September 7, 2020
상단여백
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment by Lee Han-soo 2019-08-22 14:36
K-Hospital Fair 2019 opens 3-day show in Seoul by Lee Han-soo 2019-08-21 23:36
Chong Kun Dang invests ₩5 billion in Biorchestra by Lee Han-soo 2019-08-21 16:42
‘GSK’s hair loss treatment Avodart works well for Koreans’ by Lee Han-soo 2019-08-20 17:46
JW’s European partner launches 3rd-gen parenteral nutrition solution in EU by Lee Han-soo 2019-08-20 17:46
라인
Genexine, Toolgen merger deal falls through by Lee Han-soo 2019-08-20 11:21
Combo drugs: latest trend in local pharmaceuticals by Lee Hye-seon 2019-08-19 16:02
Boryung to sell antihypertensive drugs in Mexico by Lee Han-soo 2019-08-19 14:31
Rivalry among PARP inhibitors intense in ovarian cancer treatment by Kim Yun-mi 2019-08-19 14:00
Local drugmakers speed up NASH drug development by Lee Hye-seon 2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales by Lee Han-soo 2019-08-14 17:22
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga by Lee Han-soo 2019-08-14 16:17
Korean firms eyeing on growing orphan drug market by Jeong Sae-im 2019-08-14 14:48
Huons Global hits record-high 1H sales by Lee Han-soo 2019-08-14 14:46
Court dismisses Kolon's petition to suspend government's step on Invossa by Lee Han-soo 2019-08-14 11:57
라인
Hugel posts ₩50.3 billion in Q2 sales by Lee Han-soo 2019-08-13 18:13
Last trial OKed for Eylea to prevent blindness in premature infants by Lee Hye-seon 2019-08-13 12:42
Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status by Lee Han-soo 2019-08-13 11:12
Roche wins additional indication for breast cancer treatment Kadcyla by Lee Han-soo 2019-08-12 15:17
Yuhan can continue testing lung cancer drug Lazertinib by Lee Hye-seon 2019-08-12 12:58
여백
여백
여백
Back to Top